Znn3bq.jpeg
²é¿´: 566  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ²©Ñ§EPI £¬µã»÷ÕâÀï½øÐв鿴

hzlx

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] ÇóÎÄÏ×·­ÒëÒ»¶Î

Primary and Secondary Binding Experiments. Radioligand binding assays using cloned GPCRs, ion channels, and transporters were performed using membranes from transiently transfected or stable cell lines as previously detailed(1, 46) through the resources of the National Institute of Mental Health Psychoactive Drug Screening Program. Detailed protocols (including cell handling, buffer composition, assay conditions, etc.) for all assays are available online.(https://pdsp.med.unc.edu/UNC-CH%20Protocol%20Book.pdf)
Initial screening assays were performed using a 10-¦ÌM (final concentration)test compound, and the percent inhibition of specific binding by the test  compound was determined. When the test compound inhibited >50% of radioligand specific binding, Ki determinations were performed by measuring the inhibition of radioligand binding by various concentrations of test drug (11 concentrations spanning six orders of magnitude). Radioligand binding isotherms were regressed using the One Site Competition Binding function built into Prism 4.0 (GraphPad) to estimate compound IC50 values. Affinity constants (Ki values) were calculated from IC50 values using the Cheng¨CPrusoff approximation.
    Representative Procedures.

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

308647707

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

hzlx(½ð±Ò+80, ²©Ñ§EPI+1): 2011-07-21 23:35:19
½áºÏÊ×ÒªºÍ´ÎҪʵÑé·½°¸£¬·ÅÉäÐÔÅäÌå½áºÏʹÓÿË¡GPCRs¼ì²â·¨¡¢Àë×ÓͨµÀºÍתÔË·¨ÓÃÓÚ¶ÌÔÝתȾ»òÎȶ¨Ï¸°ûϵµÄϸ°ûĤ£¬Ïêϸ²ÎÕÕ(1,46)ͨ¹ýÃÀ¹ú¹ú¼Ò¾«ÉñÎÀÉúÑо¿Ôº¹ØÓÚ¾«Éñ´Ì¼¤Ò©Îïɸѡ³ÌÐòµÄ×ÊÔ´¡£ËùÓÐÊÔÑéµÄÏêϸЭÒ飨°üÀ¨Ï¸°û´¦Àí,»º³å×é³É£¬²â¶¨Ìõ¼þµÈ£©¿É²ÎÕÕ.(https://pdsp.med.unc.edu/UNC-CH%20Protocol%20Book.pdf)
Ê×ҪɸѡÊÔÑéʹÓÃÒ»¸ö10-¦ÌMµÃ²âÊÔ»¯ºÏÎĩŨ¶È£©£¬ÒÖÖÆ°Ù·Ö±ÈµÄÌØÊâ½áºÏÐÔͨ¹ý²âÊÔ»¯ºÏÎïÀ´¾ö¶¨£¬µ±²âÊÔ»¯ºÏÎïµÄÒÖÖÆ°Ù·Ö±È>50%·ÅÉäÐÔÅäÌåʱ£¬Í¨¹ý¸÷ÖÖŨ¶ÈµÄ²âÊÔÒ©Î11Ũ¶È²ÉÓÃÁù¸öÊýÁ¿¼¶£©²âÁ¿·ÅÉäÐÔÅäÌåµÄÒÖÖÆ°Ù·Ö±ÈÀ´¾ö¶¨Ki£¬·ÅÉäÐÔÅäÌåµÄµÈÎÂÏß·´¸´Ê¹ÓÃÒ»¸öµØÖ·¾ºÕù½áºÏ×÷Óý¨Á¢Àâ¾µ4.0(GraphPad£©À´¹ÀË㻯ºÏÎïIC50 µÄÖµ£¬Ç׺ͳ£Êý£¨KiÖµ£©¿ÉÒÔͨ¹ýCheng¨CPrusoff ½üËÆ·¨µÃµ½µÄIC50Öµ¼ÆËã³öÀ´¡£
Óдú±íÐԵijÌÐò¡£
2Â¥2011-07-21 22:44:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ hzlx µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 296Çóµ÷¼Á +5 Íô£¡£¿£¡ 2026-04-09 5/250 2026-04-09 17:47 by ÄûÃʲ»Ëázy
[¿¼ÑÐ] 293Çóµ÷¼Á +3 ÓÂÔ¶¿â°®314 2026-04-08 3/150 2026-04-09 15:51 by wp06
[¿¼ÑÐ] 085501»úеר˶ 302·Ö ²»ÌôרҵÇóµ÷¼Á +5 Íôij. 2026-04-09 5/250 2026-04-09 15:38 by ½¯ð©Óí
[¿¼ÑÐ] 265Çóµ÷¼Á +4 ·ç˵ËýÔçÍüÁË 2026-04-07 4/200 2026-04-09 13:59 by onlyÖÜ
[¿¼ÑÐ] 328Çóµ÷¼Á +17 lftmya 2026-04-07 18/900 2026-04-09 08:05 by 5268321
[¿¼ÑÐ] ²ÄÁÏ334Çóµ÷¼Á +21 Eecho# 2026-04-03 21/1050 2026-04-08 22:55 by Öí»á·É
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +21 ÄãºÃÃ÷ÌìÄãºÃ 2026-04-07 23/1150 2026-04-08 22:32 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] 285Çóµ÷¼Á +7 ¶ñ·¨´ó¶þµÄÆøÎ¶ß 2026-04-05 10/500 2026-04-08 14:34 by zhq0425
[¿¼ÑÐ] µç×ÓÐÅÏ¢346 +4 zuoshaodian 2026-04-08 4/200 2026-04-08 11:54 by zzucheup
[¿¼ÑÐ] 316Çóµ÷¼Á +7 yyxÏëµ÷¼Á 2026-04-05 7/350 2026-04-07 14:31 by shdgaomin
[¿¼ÑÐ] 295Çóµ÷¼Á +18 xndjjj 2026-04-04 19/950 2026-04-07 11:02 by wangjy2002
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á ¿Éµ÷¼Áµ½ÉúÎïÓëÒ½Ò© +3 ÀîÕþÓ¨ 2026-04-06 3/150 2026-04-06 19:02 by macy2011
[¿¼ÑÐ] Çóµ÷¼Áµ½²ÄÁÏ +5 ³Ì9915 2026-04-06 5/250 2026-04-06 15:21 by yulian1987
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +5 asdasdassda 2026-04-05 5/250 2026-04-06 09:32 by dongzh2009
[¿¼ÑÐ] 295Çóµ÷¼Á +8 FZAC123 2026-04-03 8/400 2026-04-05 17:46 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +6 cs0106 2026-04-05 6/300 2026-04-05 16:34 by imissbao
[¿¼ÑÐ] Ò»Ö¾Ô¸½­ÄÏ´óѧ085501»úе¹¤³Ìר˶326·Ö£¬±¾¿Æ¼Ñľ˹´óѧ +5 ¹ËÈô¸¡Éú 2026-04-03 9/450 2026-04-05 09:57 by 1753564080
[¿¼ÑÐ] 344²ÄÁÏÓ뻯¹¤µ÷¼Á +9 µ÷¼ÁÉϰ¶«^ 2026-04-03 9/450 2026-04-04 23:10 by happyddm
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«±±´óѧ085901ÍÁľר˶345Çóµ÷¼Á +3 zxt11111 2026-04-04 3/150 2026-04-04 14:21 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] »¯¹¤Çóµ÷¼Á +11 ÀóÏã֥ʿҬÄÌ 2026-04-03 11/550 2026-04-03 22:06 by à£à£à£0119
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û